Rosen, National Investor Counsel, AstraZeneca PLC encourages investors to seek advice before important deadlines in securities Class Actions First filed by the firm

Spread the love

NEW YORK, NY–(The News File Corporation – January 20, 2025) – why: Rosen Law Firm, a global investor rights law firm, is recalling the warrants of AstraZeneca PLC (NASDAQ: LON: ) covering both dates between February 23, 2022 and December 17, 2024 (the “Class Period”). February 21, 2025 lead plaintiff deadline First in a surety class action filed by the company.

So what? If you purchase AstraZeneca (NASDAQ:) securities during the Class Period, you may receive compensation through a contingent payment arrangement without paying any out-of-pocket fees or expenses.

What to do next: To join an AstraZeneca class action, go to or call Philip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information. A class action lawsuit has already been filed. If you want to serve as lead plaintiff, you must move the court After February 21, 2025. A lead plaintiff is a representative party who conducts litigation on behalf of other class members.

Why the Rose Rule? We encourage investors to select a qualified advisor with a track record of success in a leadership role. Oftentimes, the organizations that issue the ads don’t have comparable experience, resources, or any meaningful peer recognition. Most of these firms do not litigate securities class actions but are intermediaries who refer clients or litigate cases with law firms. Be wise when choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder derivative litigation. Rosen Law Firm won the largest securities class action against a Chinese company at the time. Rosen Law Firm is rated Class 1 by ISS Securities Action (WA:) Services in 2017 for the securities division of the action settlement number. The firm has been ranked in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In the year In 2019 alone, the company raised over $438 million for investors. In the year In 2020, founding partner Lawrence Rosen was named a Titan of the Plaintiffs Bar by Law360. Many of the firm’s lawyers are accredited by Laudragon and Super Lawyers.

Details of the case:- According to the lawsuit, the class-action defendants made materially false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which ultimately led to the arrest of AstraZeneca China’s president by Chinese law enforcement authorities; (3) as a result, AstraZeneca mitigated its legal risks; (4) the foregoing, once disclosed, could materially harm AstraZeneca’s business in China; and (5) as a result, the defendants’ representations about its business, operations and prospects are materially false and misleading and/or lack a reasonable basis at all material times. The lawsuit alleges that investors were harmed when the real listings entered the market.

To join an AstraZeneca class action, go to Call Philip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information.

No class confirmed. Unless a unit is confirmed, you will not be represented by a consultant unless you have booked one. You can choose the advice of your choice. You can also remain a member of a class you are not in and do nothing at this point. An investor’s ability to participate in any future recovery is not dependent on serving as the lead plaintiff.

Notice of attorney. Previous results do not guarantee the same result.

————————————-

Contact Information:

To view the source of this press release, please visit https://www.newsfilecorp.com/release/237728.